Sched.com Conference Mobile Apps
DIA Europe 2019
has ended
Create Your Own Event
DIA Europe 2019
-
Saved To
My Schedule
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
01 Stakeholders and Regulatory System Optimisation
All
Session
02 Evolution of Science and Policy
All
Session
03 Pharmacovigilance
All
Session
04 Modern Clinical Research
All
Session
05 Medical Affairs and Communication
All
Session
06 Access to Medicines
All
Session
07 Digital Disruptors
All
Session
08 Regional Updates
All
Session
Conference Closer
Content Hub
All
Session
DIAmond Sessions
All
Session
Executive Forum
All
Session
Hot Topics/Stand Alone
All
Session
ICH Info Day
All
Session
Keynote
All
Session
Leader of Tomorrow
All
Session
Networking
All
Social Event
Opening Plenary
All
Session
Poster Session
All
Session
Short Courses
All
Tutorial
Spotlight Sessions
All
Session
Women in Leadership
All
Session
Sign up
or
log in
to bookmark your favorites and sync them to your phone or calendar.
menu
Menu
Schedule
Speakers
Search
tune
Filter sessions
Simple
Expanded
Grid
By Venue
arrow_back
View All Dates
Wednesday
, February 6
0.11-0.12 (Level 0)
15:15 •
#SP01: Nanomedicines and Nanosimilars – Implications for Regulators, Payers and Prescribers
0.96-0.97 (Level 0)
12:00 •
#LOT02: How is R&D Being Reflected in Academia vs Industry
15:15 •
#LOT04: Value and Access
16:45 •
#LOT03: Regulatory Affairs: Career Opportunities and Field Development
Content Hub 1
10:45 •
#CH101: Finding The Right Formula – The Ups and Downs of a Consumer Group’s Work With Industry 2010-2018
11:15 •
#CH102: The Language of Patients Meets the Language of Safety Science
12:00 •
#CH103: EUPATI Update
Content Hub 2
10:15 •
#CHS01: New Legislative Requirements in PV: How to Be More Efficient and Minimise Resources
14:45 •
#CHS04: Navigating the Regulatory Landscape for Safety Reporting in Clinical Trials: Key Principles, Best Practices, and Upcoming Automation
15:15 •
#CH201: Recent Developments and Possibilities in Using CPRD as a ‘Real World Data Source’
15:45 •
#CH202: Collaborating to Solve the Industry’s Toughest Challenges: Maximizing the Regulator-Sponsor Relationship
16:15 •
#PS06: Oral Poster Session 6 - Clinical Development & Pharmacovigilance Content Hub
Content Hub 3
10:45 •
#CH301: Development of an Algorithm to Detect Antibiotic-induced Acute Kidney Injury Using Electronic Medical Records
11:15 •
#CH302: AI on the Rise - digitally transforming pharma’s regulatory processes
14:15 •
#PS05: Oral Poster Session 5 - Translational Medicines and Science & Data and Data Standards Content Hub
16:45 •
#CH303: Repurposing - Working Together on New Uses for Old Drugs
17:15 •
#CH304: New Changes to the National Drug Code in the U.S.
Content Hub 4
10:15 •
#PS04: Oral Poster Session 4 - Regulatory Science & Value and Access Content Hub
11:15 •
#CH402: Policy 0070 Submissions – Comparison of Anonymisation Methodologies – Advantages and Disadvantages
12:00 •
#CH403: Bridging the Gap between Managed Healthcare and Clinical Research
12:30 •
#CH406: Unmet Medical Need Papers
15:15 •
#CH404: EMA Policy 0070 - Arguing for a Pro-Active Anonymisation Process and External Validation of Identification Risk and Utility
15:45 •
#CH405: Aligning expectations for product label terminology: disease modification in neurodegenerative disorders as a case example
DIAlogue Space
10:45 •
#S0401: Re-Thinking Clinical Development
12:00 •
#S0702: Blockchain in Healthcare and Pharma
13:30 •
#LS01: Debate: Does the Future Legislative Framework in the EU Need Transformative Legislative change? Or Have We ‘Almost Got It Right’?
15:15 •
#S0903: Histology-Independent Indications
16:45 •
#S0104: Evidence Generation as a Continuum: Can We Benefit from Advice?
E1
08:30 •
#KN2: Will Virtual Patients Allow for Virtual Trials?
09:15 •
#DMD7: Digital Trials, Sensors, Bots, AI/Machine Learning, RWD– Will Product Approvals Be Accelerated By These New Technologies?
10:45 •
#S0101: Optimising Orphan Drug Development in the EU
12:00 •
#S0102: Optimising Paediatric Drug Development in the EU
15:15 •
#S0103: The Regulatory Role in EU Public-Private Partnerships (PPPs)
16:45 •
#S0904: Fighting Falsified Medicines in Europe –Supply Chain Digitalisation for the Benefit of Patients: Are You Ready?
E2
09:15 •
#DMD8: EU Cooperation on HTA and beyond - Current Action and Future Developments
10:45 •
#S0301: Impact of Pharmacovigilance on Public Health
12:00 •
#S0302: Forum on Global Pharmacovigilance
15:15 •
#S0303: The New EudraVigilance System: One Year After
Exhibition Hall
10:15 •
#CB2: Coffee Break in the Exhibition Hall
13:15 •
#L2: Lunch in the Exbition Hall
16:15 •
#CB3: Coffee Break in the Exhibition Hall
18:00 •
#NW02: Networking Reception in the Exhibition Hall
F1
09:15 •
#DMD9: Brexit and the European Network: 1,5 months to go! Where Do We Stand?
10:45 •
#S0901: Clinical Trials and GDPR
12:00 •
#S0402: Where Will Patients Come from in the Future? EHR and Biobanks
15:15 •
#S0403: Change is Coming… Getting the Questions Right in Clinical Development
16:45 •
#S0404: Study Design and Innovative Statistics
F2
10:45 •
#S0701: Digital Disruptors: What Do We Mean?
12:00 •
#S0202: How Can the EU Regulatory Network Support Innovation?
15:15 •
#S0703: The Digital Transformation of Clinical Trials and its Regulatory Implications – What are the Challenges?
16:45 •
#S0704: Digital Innovation is Revolutionising All Aspects of Trial Execution: Opportunities and Requirements
G1
10:45 •
#S0201: The Digital Transformation in Regulatory Affairs – What is Hype and What is Real?
12:00 •
#S0902: Next Generation Sequencing-Based Comprehensive Genomic Profiling: A Paradigm Shift in Clinical Practice
15:15 •
#S0803: Updates from the Middle East Region: Key Insights from Agencies & Industry on the Regulatory Environment, Opportunities and the Challenges; Sharing Best Practices of Reliance Model Implementation
16:45 •
#S0204: Patient Preferences – The Science of Tomorrow
G2
10:45 •
#S0501: The Added Value of Medical Functions: Building a Long-Term Strategy
12:00 •
#S0502: Creating Value for Patients
15:15 •
#S0503: Medical Functions Contribution to Benefit-Risk Assessment
16:45 •
#S0504: Dialog with Patients - Moving Forward with Digital Information
K1
10:45 •
#S0601: From Faster Regulatory Approval to Actual Patient Access: What Could be Done to Increase Certainty around Clinical Benefit and Predictability of Decision Making?
12:00 •
#S0602: Incorporation and Acceptance of Real World Evidence in Market Access Discussions – Case Studies
15:15 •
#S0603: Value Assessment of Combinations in Oncology (or others): Questions and Steps toward Practical Solutions
16:45 •
#S0604: Outcomes Measurement: The Key to Value-Based Healthcare
K2
10:45 •
#S0801: The Impact of Innovation and Novel Pathways: The Role of the Regulator
12:00 •
#S0802: Driving for Regulatory Excellence in Turkey
15:15 •
#S0203: Precision Medicine: Gene-Editing, Advance Therapies and Personalised Medicine
16:45 •
#S0804: Update on PMDA’s Activities
TBD
16:45 •
#S0304: Decision Science, Communication and Pharma Comparing Older People to Younger Ones with Regard to Making Decisions about Taking Pharmaceuticals
Timezone
DIA Europe 2019
Europe/Paris
Filter By Date
DIA Europe 2019
Feb 4
-
7, 2019
Monday
, February 4
Tuesday
, February 5
Wednesday
, February 6
Thursday
, February 7
Filter By Venue
Vienna, Austria
Sort schedule by Venue
0.11-0.12 (Level 0)
0.94-0.95 (Level 0)
0.96-0.97 (Level 0)
Content Hub 1
Content Hub 2
Content Hub 3
Content Hub 4
DIAlogue Space
E1
E2
Exhibition Hall
F1
F2
G1
G2
Hall D
K1
K2
TBD
Filter By Type
01 Stakeholders and Regulatory System Optimisation
All
Session
02 Evolution of Science and Policy
All
Session
03 Pharmacovigilance
All
Session
04 Modern Clinical Research
All
Session
05 Medical Affairs and Communication
All
Session
06 Access to Medicines
All
Session
07 Digital Disruptors
All
Session
08 Regional Updates
All
Session
Conference Closer
Content Hub
All
Session
DIAmond Sessions
All
Session
Executive Forum
All
Session
Hot Topics/Stand Alone
All
Session
ICH Info Day
All
Session
Keynote
All
Session
Leader of Tomorrow
All
Session
Networking
All
Social Event
Opening Plenary
All
Session
Poster Session
All
Session
Short Courses
All
Tutorial
Spotlight Sessions
All
Session
Women in Leadership
All
Session
Filter sessions
Apply filters to sessions.
Filtered by
Date
-
Clear filter
close
Dates
Monday
, February 4
Tuesday
, February 5
Wednesday
, February 6
Thursday
, February 7
Venue
0.11-0.12 (Level 0)
0.94-0.95 (Level 0)
0.96-0.97 (Level 0)
Content Hub 1
Content Hub 2
Content Hub 3
Content Hub 4
DIAlogue Space
E1
E2
Exhibition Hall
F1
F2
G1
G2
Hall D
K1
K2
TBD
Session Type
01 Stakeholders and Regulatory System Optimisation
All
Session
02 Evolution of Science and Policy
All
Session
03 Pharmacovigilance
All
Session
04 Modern Clinical Research
All
Session
05 Medical Affairs and Communication
All
Session
06 Access to Medicines
All
Session
07 Digital Disruptors
All
Session
08 Regional Updates
All
Session
Conference Closer
Content Hub
All
Session
DIAmond Sessions
All
Session
Executive Forum
All
Session
Hot Topics/Stand Alone
All
Session
ICH Info Day
All
Session
Keynote
All
Session
Leader of Tomorrow
All
Session
Networking
All
Social Event
Opening Plenary
All
Session
Poster Session
All
Session
Short Courses
All
Tutorial
Spotlight Sessions
All
Session
Women in Leadership
All
Session
Other Filters